Accelovance’s Stephen Trevisan And Robert deGroof On China’s Clinical Research Landscape: An Interview With PharmAsia News (Part 1 of 2)

Accelovance CEO Stephen Trevisan and Chief Scientific Officer Robert deGroof recently spoke with PharmAsia News about the evolving landscape for conducting clinical trials in China. Accelovance, based in Rockville, Md., has 10 clinical sites in the U.S. and a wholly owned enterprise in China with offices in Beijing and Shanghai to provide International Conference on Harmonization-good clinical practices compliant clinical trials.